173 related articles for article (PubMed ID: 4334867)
1. The morphological substrate of the inhibition of insulin secretion by diazoxide.
Creutzfeldt W; Creutzfeldt C; Frerichs H; Perings E; Sicklinger K
Horm Metab Res; 1969 Mar; 1(2):53-64. PubMed ID: 4334867
[No Abstract] [Full Text] [Related]
2. [Morphology and histochemistry of insulin secretion].
Creutzfelt W
Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():387-416. PubMed ID: 4313827
[No Abstract] [Full Text] [Related]
3. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
Loubatières A; Mariani MM; Alric R
Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
[No Abstract] [Full Text] [Related]
4. Diazoxide and D600 inhibition of insulin release. Distinct mechanisms explain the specificity for different stimuli.
Henquin JC; Charles S; Nenquin M; Mathot F; Tamagawa T
Diabetes; 1982 Sep; 31(9):776-83. PubMed ID: 6131003
[No Abstract] [Full Text] [Related]
5. [Insulin secretion in vitro. II. Inhibition of glucose induced insulin release by diazoxide].
Frerichs H; Gerber R; Creutzfeldt W
Diabetologia; 1966 Dec; 2(4):269-76. PubMed ID: 4902707
[No Abstract] [Full Text] [Related]
6. Insulin and glucagon release from isolated islets of Langerhans. Effect of enteric factors.
Buchanan KD; Vance JE; Williams RH
Diabetes; 1969 Jun; 18(6):381-6. PubMed ID: 4892443
[No Abstract] [Full Text] [Related]
7. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells.
Schöfl C; Börger J; Mader T; Waring M; von zur Mühlen A; Brabant G
Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E639-47. PubMed ID: 10751197
[TBL] [Abstract][Full Text] [Related]
8. Diazoxide and the secretion of insulin.
Nutr Rev; 1972 Aug; 30(8):194-8. PubMed ID: 4340200
[No Abstract] [Full Text] [Related]
9. [Experimental study of a new especially active hypoglycemic sulfonamide, HB-419 or Glibenclamide].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Chapal J
Diabetologia; 1969 Feb; 5(1):1-10. PubMed ID: 4907149
[No Abstract] [Full Text] [Related]
10. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
Seltzer HS; Crout JR
Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
[No Abstract] [Full Text] [Related]
11. Comparison of the inhibitory effects of diphenylhydantoin and diazoxide upon insulin secretion from the isolated perfused pancreas.
Levin SR; Grodsky GM; Hagura R; Smith D
Diabetes; 1972 Aug; 21(8):856-62. PubMed ID: 4558084
[No Abstract] [Full Text] [Related]
12. The use of diazoxide inhibition of insulin secretion as a tool to investigate insulin stimulation by other agents.
Gulbenkian A; Ornstein L; Tabachnick II
Horm Metab Res; 1972 Mar; 4(2):57-8. PubMed ID: 5028220
[No Abstract] [Full Text] [Related]
13. Study on the formation and release of insulin with special reference to electron microscopic observation.
Yokoo S; Aozi O; Okumura K; Fujii M; Yoshida H
Arch Histol Jpn; 1966 Nov; 27(1):287-96. PubMed ID: 5339931
[No Abstract] [Full Text] [Related]
14. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
[No Abstract] [Full Text] [Related]
15. Cyclosporine inhibition of insulin secretion: effect of tolbutamide and extracellular calcium concentration.
Bartlett ST; Gillison SL; Curry DL
Transplant Proc; 1990 Apr; 22(2):749-53. PubMed ID: 2183445
[No Abstract] [Full Text] [Related]
16. Improvement in insulin secretion in diabetes after diazoxide.
Greenwood RH; Mahler RF; Hales CN
Lancet; 1976 Feb; 1(7957):444-7. PubMed ID: 55717
[TBL] [Abstract][Full Text] [Related]
17. [Normal histology of the beta-cells during insulin secretion].
Bänder A
Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():417-35. PubMed ID: 4907224
[No Abstract] [Full Text] [Related]
18. [Sulfonamides modifying insulin secretion and the development of the islands of Langerhans. Actions and antagonisms of actions. Some experimental studies of their clinical applications].
Loubatières A; Mariani MM; Alric R
Bull Acad Natl Med; 1967 Dec; 151(33):683-94. PubMed ID: 4866937
[No Abstract] [Full Text] [Related]
19. Insulinotropic effect and possible mode of action of a new potent sulfonylurea (BS-4231).
Brisson GR; Malaisse WJ
Can J Physiol Pharmacol; 1971 Jun; 49(6):536-44. PubMed ID: 4932540
[No Abstract] [Full Text] [Related]
20. [Recent pharmacologic aspects of sulfamides modifying insulin secretion (hypoglycemic and hyperglycemic sulfamides)].
Loubatiéres A; Mariani MM
Actual Physiol Pathol (Paris); 1973; 4():237-66. PubMed ID: 4219256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
